PRESS & NEWS

CurePSP Ask the Scientist: March 18, 2021

CurePSP-Ask-Scientist-2021-03-18

CurePSP will host an Ask the Scientist webinar on Thursday, March 18, 2021, when Dr. Günter U. Höglinger will discuss two new PSP scales: mPSPRS and PSP-CDS. The hour-long, online session begins at 11:00 a.m. Easter Daylight Time (8:00 a.m. Pacific). The Progressive Supranuclear Palsy (PSP) Rating Scale is a prospectively validated, physician-rated measure of…

CurePSP will host an Ask the Scientist webinar on Thursday, March 18, 2021, when Dr. Günter U. Höglinger will discuss two new PSP scales: mPSPRS and PSP-CDS. The hour-long, online session begins at 11:00 a.m. Easter Daylight Time (8:00 a.m. Pacific).

The Progressive Supranuclear Palsy (PSP) Rating Scale is a prospectively validated, physician-rated measure of disease severity for persons diagnosed with PSP. According to experts’ opinion, individual scores of items would differ in relevance for patients’ quality of life, functionality in daily living, and mortality.

This webinar is technical in nature and is intended for research and healthcare professional audiences.

About Günter U. Höglinger

Professor Höglinger conducts research in the field of neurodegenerative Parkinson syndromes with the goal of understanding the molecular mechanisms leading to the development and progression of neuronal dysfunction and death and of using these findings for diagnostic and therapeutic purposes. His particular focus is the interface between preclinical and clinical research.

Dr. Höglinger studied medicine and physics at the universities of Regensburg and Würzburg. He earned his Ph.D. in medicine, summa cum laude, in 2000. Supported by a grant from the German Research Foundation, DFG, he worked as a postdoctoral researcher at the Hôpital de la Salpêtrière in Paris.

Since 2004 he has directed the experimental neurology research group at Philipps University Marburg. In Marburg, he also acquired his German medical board certification in neurology and worked as the Vice Director of the Department of Neurology.

Since 2011 he has worked as a senior consultant at TUM’s Department of Neurology and holds the Chair of the Department of Translational Neurodegeneration at the German Center for Neurodegenerative Diseases, DZNE. Since 2019, he has served as the President of the German Parkinson Association.

Together we can find a cure for ftd

The FTD Disorders Registry is a powerful tool in the movement to create therapies and find a cure. Together we can help change the course of the disease and put an end to FTD.

Your privacy is important! We promise to protect it. We will not share your contact information.

Read Full Privacy Statement